Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II

NCT03011541 is registered in ClinicalTrials.gov with MD Stem Cells as lead sponsor.

NCT NCT03011541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03011541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II
Lead sponsor
MD Stem Cells
Phase
Not applicable
Overall status
Recruiting
Start date
January 31, 2016
Completion date
July 31, 2028
Enrollment
500 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, blindness, glaucoma, leber hereditary optic neuropathy, macular degeneration, maculopathy, nonarteritic ischemic optic neuropathy, optic atrophy, optic nerve disease, optic neuropathy, retina atrophy, retinal disease, retinitis pigmentosa, retinopathy, stargardt disease, vision loss night, vision loss partial, vision, low